降低血谷氨酸水平联合A2AR基因失活可显著减轻创伤性脑损伤诱导的急性肺损伤
本研究利用中度和重度创伤性脑损伤(TBI)小鼠模型,探究血谷氨酸浓度与TBI诱导急性肺损伤(TBI-ALI)的因果关系及A2AR的作用。静脉给予L-谷氨酸显著增加肺水含量、肺体指数、支气管肺泡灌洗液炎症标志物水平和急性肺损伤评分,显著降低PaO2/FiO2比值,并显著增加TBI-ALI发生率和死亡率;联合给予A2AR激活剂与外源性谷氨酸进一步加剧上述损伤。相反,通过腹膜透析或静脉给予草酰乙酸降低血谷氨酸水平可显著改善上述参数,同时联合A2AR基因失活可见进一步改善。作者认为,A2AR激活加剧高血谷氨酸对肺的损伤效应,联合靶向A2AR和血谷氨酸可能是防治TBI-ALI的有效途径。
要点
- 静脉给予L-谷氨酸可显著增加TBI小鼠肺水含量、肺体指数、支气管肺泡灌洗液炎症标志物水平和急性肺损伤评分,并显著降低PaO2/FiO2比值。
- 静脉给予L-谷氨酸显著增加TBI小鼠TBI-ALI发生率和死亡率。
- 联合给予A2AR激活剂与外源性谷氨酸进一步加剧上述肺损伤效应。
- 通过腹膜透析或静脉给予草酰乙酸降低血谷氨酸水平可显著改善上述肺损伤参数。
- 在降低血谷氨酸基础上联合A2AR基因失活可见进一步改善;作者认为联合靶向A2AR和血谷氨酸可能是防治TBI-ALI的有效途径。
适用人群与场景
- 中度和重度创伤性脑损伤小鼠模型;原文未报告临床患者纳入或排除标准。
处置流程与药物剂量
- 静脉给予L-谷氨酸用于复制高血谷氨酸加重TBI-ALI的模型;原文未报告剂量、浓度和给药频次。
- 联合给予A2AR激活剂与外源性谷氨酸用于观察进一步加重的损伤效应;原文未报告药物名称、剂量和给药方案。
- 通过腹膜透析降低血谷氨酸水平;原文未报告透析方案和疗程。
- 静脉给予草酰乙酸降低血谷氨酸水平;原文未报告剂量、浓度和给药频次。
- 联合A2AR基因失活用于观察进一步改善效应。
研究设计与关键结果
- 研究类型为小鼠模型实验,使用中度和重度TBI模型;静脉给予L-谷氨酸后肺水含量、肺体指数、支气管肺泡灌洗液炎症标志物水平和急性肺损伤评分均大幅增加,PaO2/FiO2比值显著降低。
- 静脉给予L-谷氨酸后TBI-ALI发生率和死亡率显著增加;联合给予A2AR激活剂与外源性谷氨酸进一步加剧上述损伤效应。
- 通过腹膜透析或静脉给予草酰乙酸降低血谷氨酸水平后上述参数显著改善;同时联合A2AR基因失活可见进一步改善。
证据类型、等级与局限
- 证据类型:动物实验(小鼠模型);原文未报告证据等级或推荐强度。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,A2AR激活加剧高血谷氨酸浓度对肺的损伤效应,联合靶向A2AR和血谷氨酸可能是预防和治疗TBI-ALI的有效途径。
- 原文结果来自小鼠模型,原文未据此给出临床推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Traumatic brain injury-induced acute lung injury (TBI-ALI) is a serious complication of traumatic brain injury (TBI). Our previous clinical study found that high levels of blood glutamate after TBI were closely related to the occurrence and severity of TBI-ALI, while it remains unknown whether a high concentration of blood glutamate directly causes or aggravates TBI-ALI. We found that inhibition of the adenosine A2A receptor (A2AR) after brain injury alleviated the TBI-ALI; however, it is unknown whether lowering blood glutamate levels in combination with inhibiting the A2AR would lead to better effects. Using mouse models of moderate and severe TBI, we found that intravenous administration of L-glutamate greatly increased the lung water content, lung-body index, level of inflammatory markers in bronchoalveolar lavage fluid and acute lung injury score and significantly decreased the PaO2/FiO2 ratio. Moreover, the incidence of TBI-ALI and the mortality rate were significantly increased, and the combined administration of A2AR activator and exogenous glutamate further exacerbated the above damaging effects. Conversely, lowering the blood glutamate level through peritoneal dialysis or intravenous administration of oxaloacetate notably improved the above parameters, and a further improvement was seen with concurrent A2AR genetic inactivation. These data suggest that A2AR activation aggravates the damaging effect of high blood glutamate concentrations on the lung and that combined treatment targeting both A2AR and blood glutamate may be an effective way to prevent and treat TBI-ALI.
参考来源
- Bai W, Li P, Ning YL, et al. Reduction in Blood Glutamate Levels Combined With the Genetic Inactivation of A2AR Significantly Alleviate Traumatic Brain Injury-Induced Acute Lung Injury. Shock. 2019. PMID: 29688987. doi:10.1097/SHK.0000000000001170
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。